Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

A House subcommittee will hold a hearing today covering safety lapses and improvements to be made to the organ donor system. In other news: the FDA's debate on antidepressant use during pregnancy; the ...

George Tidmarsh is a millionaire co-founder of a biotech firm, serial entrepreneur, neonatologist and adjunct professor at ...

The US regulator has tapped Stanford University physician-scientist and former biotech executive George Tidmarsh to serve as ...

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

Astronomer's new CEO is speaking out about the Coldplay concert kiss cam controversy, admitting the viral video has raised ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

The FDA appointed George F. Tidmarsh, MD, PhD, the director of the Center for Drug Evaluation and Research, the agency ...